The company identified 7 studies from the clinical evidence search which incorporated an economic analysis. However, it was unable to draw any firm conclusions from these studies. The external ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced today that the Spectra Optia system mononuclear cell (MNC) collection protocol is now cleared by the U.S. Food and Drug Administration (FDA) and ...
Terumo's Spectra Optia® Apheresis System Terumo's Spectra Optia® Apheresis System LAKEWOOD, Colo., U.S., and SANTA ROSA, Calif., U.S., July 27, 2022 (GLOBE NEWSWIRE) -- Acute kidney injury (AKI) and ...
The Spectra Optia(R) Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT system can now be used to provide extracorporeal photopheresis immunotherapy The company is ...
AllAfrica on MSN
Victoria Hospital in Kisumu becomes first public facility in Kenya to offer advanced sickle cell treatment
KISUMU, Kenya, Jan 26 -- Victoria Hospital in Kisumu, an annex of the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), has become the first public hospital in Kenya to acquire a ...
The rollout marks a major step in reducing childhood deaths from sickle cell disease through early screening and advanced ...
LAKEWOOD, Colorado, April 6, 2017 /PRNewswire/ --Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that the SpectraOptia ® Apheresis ...
Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia(R) Apheresis System at major conferences Lakewood, Colorado, US, May 25, 2023 – Terumo Blood and ...
LONDON, Feb. 14, 2024 /PRNewswire/ -- Children, young people, and adults across England suffering from sickle cell disease will soon benefit from better care closer to where they live, following the ...
The experiences of NHS trusts have been used to develop practical suggestions for how to implement NICE guidance on the use of Spectra Optia for automated red cell exchange. The first step is to form ...
LAKEWOOD, Colorado, April 6, 2017 /PRNewswire/ -- Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced that the Spectra Optia ® Apheresis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results